Andrew Green

Assistant Professor

University of Nottingham

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Andrew Green is an Assistant Professor at the University of Nottingham, UK. His research primarily focuses on breast cancer, with recent publications exploring the roles of various proteins and metabolic pathways in disease progression and patient outcomes. His work includes studies on invasive lobular carcinoma, glutamine metabolism, and the expression of key biomarkers in different breast cancer subtypes.

Articles (12)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (8)

Nigel Mongan

Professor of Oncology

University of Nottingham

UNITED KINGDOM

View details

Stewart Martin

Prof

University of Nottingham

UNITED KINGDOM

View details

Thomas E. Yankeelov

University of Texas at Austin

UNITED STATES

View details

Mohammed Aleskandarany

Senior Lecturer of Pathology

University of Derby

UNITED KINGDOM

View details

Klaus Pors

Prof

University of Bradford

UNITED KINGDOM

View details

S Sneha

University of Bradford

UNITED KINGDOM

View details

Ian Ellis

Professor of Cancer Pathology

University of Nottingham

UNITED KINGDOM

View details

Ali Fakroun

University of Nottingham

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrew Green

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Protein Tyrosine Kinase 7 (PTK7) in Breast Cancer: A Retrospective Analysis of Tumour Expression and Association with Clinical Outcome

Deciphering the Clinical Behaviour of Invasive Lobular Carcinoma of the Breast Defines an Aggressive Subtype

Tripartite Motif-Containing 2, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Triple-Negative Breast Cancer Treated with Chemotherapy

Hydroxyacid Oxidase 1, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Luminal Breast Cancer.

Deciphering the Role of ASPM in Breast Cancer: A Comprehensive Multicohort Study

A Case Series Exploration of Multi-Regional Expression Heterogeneity in Triple-Negative Breast Cancer Patients

Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer

The Biological and Clinical Significance of Glutaminase in Luminal Breast Cancer

Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies

Biology of Oestrogen-Receptor Positive Primary Breast Cancer in Older Women with Utilisation of Core Needle Biopsy Samples and Correlation with Clinical Outcome

Cytoplasmic Cyclin E Is an Independent Marker of Aggressive Tumor Biology and Breast Cancer-Specific Mortality in Women over 70 Years of Age

Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer

Collaborators (8)

Nigel Mongan

Stewart Martin

Thomas E. Yankeelov

Mohammed Aleskandarany

Klaus Pors

S Sneha

Ian Ellis

Ali Fakroun

Make your next move.